昭衍新药2025年度报告
（於中華人民共和國註冊成立的股份有限公司）股份代號：6127 2025年度報告 267910113035618592949698101 H20212 26C320212 16202512 315711.00AH 33191920 20251 2320251 23 5100176 20251 2320251 2320251 2320251 2320251 2320251 23 H 1617 202512 5 202512 5 202512 5202512 5202512 5 20251 2320251 2320251 2320251 23 5100176 108 20251 2320251 2320251 2320251 23 20251 2320251 2320251 2320251 23 15323203-3209 20251 2320251 2320251 23 35A509100033 H6127A603127 https://www.joinnlabs.com 2025GLP 2025CRO16.5817.87%2.98302.08%2626 2025FDA(NAMs)GLPCRO 2025AINAMs CRO 2026 20263 30 I. 20252626 2025ADC 2025 1 (1) NMPAFDAOECDMFDSPMDAGLP20259OECDGLPGLP 20257CMAFDAOECD GLPFDA (2) (CNS) 30(CGT)PROTAC (3) BADC 300-500mgProtein A BPCR10X genomics B (ADC)INDADCADCADCADC 2010 FDAEMA 2025 2 2025 ADCPROTAC 2025IIITCEPKPK 202514CNAS 17025115(CAP) 5CCYP2C9CYP2C19(PD-L1) 3 (1) 2025(allo-HSCT)(GvHD) AAALAC2025AAALAC (2) (PBMC)(HSC)CAR-T (3) 2025(CiPSCs) 4 12CNASGLP 20259CNAS 20252600 II20,00020,000 II. 202512 311,657.6202412 312,018.317.9% 202512 311,376.6202412 311,512.89.0%202512 31 202512 31281.117.0%202412 31505.525.0%202512 31 202512 3144.9202412 31161.2127.9% 202512 3166.7202412 314.1 202512 31Biomedical Research Models Inc.Biomere81.5202412 31 202512 31514.3202412 31122.9 202512 3136.9202412 3127.932.4% 202512 31287.120241231315.99.1%202512 31 202512 3187.4202412 3192.95.9%202512 31 202512 311.4202412 312.441.9% 202512 3139.7202412 3134.315.7% 202512 3111.7%202412 3133% 202412 3169.8327.0%20251231297.8202412 313.5%2025123118.0%202512 31 202512 31 202512 3120,000 202512 3135105,000 •••••17 • ••••• 202512 31 202512 31911.9202412 31965.25.5% 202512 3114.0%202412 3114.0% 202512 31 202512 31 III. CROCRO 1 (1) 2026GLP 3ROECD/NMPA/FDAGLP (2) (PCC)FDA/EMAADMEPK-PDLC-MS/MSPDPKAI (3) GLP (4) 2 (1)+ (2) (3) 3 (1) 2026 (2) (3) 1 2 3 4 CRO 5 6 7 62199582007620208 1995820076 19868198982521992199420192 1986719928 4420121120131020208201912013320208 2012112013120131202032019720203 200582006720076201210300204 20057 581999102019120208201212 19991020054200542008620087200912 20111020235201810201911 19957 4620064 20187201712021102017120214 20066 4920077201242012520153201532021920219202311202312 4720212 20012006201020182018201920192024420245 2001620105(Carnegie MellonUniversity) 5620251199361999920119199371999920005112001220073200742009820099201512015120201220212202352023920255202562025820259 612025119877199212199212199561995620001220001220046(NIH)(NHLBI)20067820046200510201510201710202310 56202512024520202005720108200572018620247300901.SZ 44 200662007420191 44 58 46 49 5020197201972020320204 20002200232005720081220086201212012220194 2005720109(ICAEW) 20251231202512 316225 1995 9293 202512 31202520250.1220240.03749,348,2203,173,920A20252025746,174,30089,540,916202422,385,229 202512 31202512 314 202520268 31 2025 AH 9 H10%HH 12 622 H II. 34(d) 15515934(a) 202512 31 202512 31754.0 202512 3113.91C2 20243 28A0.51A2025A613,72010,333,513 202512 31H3,303,034A 20224 2820238 30202412 20 H2021226202131940,800H2021324H151.006,373.65,285.2 H20212 26202512312,886.0 13.51B(1) 10 3034 13013189 202512 31202512 31 202512 31 202512 31 202512 31 3.25C1 13.2013.21 13.22 A201720178 25 202512 31 (i) (ii) (iii) 202512 31 2022H (d) 2022HH 20226 242022H (a) (e) 2022H(i)(ii)(iii) 2022H600H H (b) 2022HH (c) 2022H (g) (f) 2022H 2022H2022H2022624102022H6 (i)(ii)(iii) (h)H 2022HH 2022H 2022HH13,238,580H197,253,168.881.77% 202512 31XV352C3 (1)A167,160,633A202512 3122.30%74,725,981A202512 319.97%3,303,034A202512 310.44%245,189,648A202512 3132.71% (3)20251231749,477,334630,482,128A3,303,034118,995,206H 202512 31XVXV78352 202512 31XV233365% (1)L(2)20251231749,477,334630,482,128A3,303,034118,995,206H(3)(1) 202512 31XV233365% 20251231887 • • 202512 312,6492019Biomere 5% 10%10%10%(1)10%(2)10%20%(3)20% 4.19%14.13% 20068 21[2006]884 13.66%27.79% 5% H [1993]045[2011]348 HH12 10%25%5% 20081110% 200811 6H[2008]897H200810% 202512 312,6492,6492,4741756(b) [2014]81HH20% 2020H (i)202512 31401(k)(ii)202512 31 37 3714A (i)202512 31(ii)202512 316(b) 202512 31 401(k)Roth 401(k)Roth5%30 2025125Biorichland LLCBiorichlandBiorichland202520281231202620272028730,992.00752,921.76775,509.413%2,226.33 A167,160,63374,725,981A241,886,614A32.27%BiorichlandBiorichland30%BiorichlandABiorichland2025 20249 120261231202414A.76(1)(a) 202414A.76(1)(a)202510 30202512312026123166.5202512 313.320240.8(i)2024(ii) 16Biorichland2025A Biorichland20250.1%5%Biorichland2025A Joinn Biologics (HK)91.07%8.93%Joinn Biologics (HK)Joinn Biologic IncJoinnBiologic IncJoinn Biologic Holdings Ltd.Joinn Biologic Holdings Ltd.55%26%Joinn Biologic Inc30%Joinn Biologic Inc2024A 202512 5 1.2024 20249 12024 20240.1%5%2024A 20%40% 202512 3116.62025123150.0202612 3147.0 202510 30 2. 202412 202025202520251 1202512 31 20028 163002048